Verastem, Inc. (VSTM)
| Market Cap | 499.80M |
| Revenue (ttm) | 80.66M |
| Net Income (ttm) | -38.66M |
| Shares Out | 171.99M |
| EPS (ttm) | -0.23 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,197,440 |
| Open | 2.82 |
| Previous Close | 2.75 |
| Day's Range | 2.74 - 2.82 |
| 52-Week Range | 1.14 - 4.93 |
| Beta | 0.78 |
| Analysts | Buy |
| Price Target | 6.25 (+126.4%) |
| Est. Earnings Date | Nov 9, 2021 |
About VSTM
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing medicines to enhance the life of cancer patients. Its product in development include VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) inhibitor that blocks MEK kinase activity and the ability of RAF to phosphorylate MEK. The company also engages in developing RAMP 201, an adaptive two-part multicenter open label trial to evaluate the efficacy and safety of VS-6766 and in combination with defactin...
Financial Performance
In 2020, Verastem's revenue was $88.52 million, an increase of 407.08% compared to the previous year's $17.46 million. Losses were -$67.73 million, -54.61% less than in 2019.
Financial StatementsAnalyst Forecast
According to 3 analysts, the average rating for Verastem stock is "Buy." The 12-month stock price forecast is 6.25, which is an increase of 126.45% from the latest price.
News
3 Biotech Stocks That Could Make You Filthy Rich
These three low-priced cancer stocks could be grossly undervalued.
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the grant of options to purchase 450,...
Top Penny Stocks To Buy The Dip According To Analysts In September
Analysts say these are penny stocks to buy right now. The post Top Penny Stocks To Buy The Dip According To Analysts In September appeared first on Penny Stocks to Buy, Picks, News and Information | Pen...
Verastem Oncology Appoints Louis J. Denis, M.D.
BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the appointment of Louis J. Denis, M....
Why Verastem Stock Spiked Today
A clinical collaboration with biotech titan Amgen briefly lit a fire underneath Verastem's shares today.
Penny Biotech Stocks: 8 Things for Verastem Investors to Know as VSTM Stock Shoots Higher
Verastem (VSTM) stock is on the rise Monday morning following an announcement from the company concerning a deal with Amgen (AMGN). The post Penny Biotech Stocks: 8 Things for Verastem Investors to Know...
Verastem Oncology and Amgen Partner to Evaluate VS-6766 in Combination with LUMAKRASTM (Sotorasib) in Patients with K...
BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq:VSTM), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced a clinical collaboration agreemen...
Verastem Shares Are Trading Higher On Encouraging Combo Therapy Data At ESMO Presentation
Verastem Oncology Inc (NASDAQ: VSTM) stock is trading higher after updated data from the ongoing Phase 1/2 FRAME study. The investigator-sponsored study is investigating VS-6766, Verastem's RAF/MEK inh...
Verastem Oncology Announces Updated Investigator-Sponsored Phase 1/2 FRAME Study Data of VS-6766 with Defactinib in L...
BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced a mini oral presentation highlighting...
Best Penny Stocks To Buy? 5 To Watch This Week With Biotech Catalysts
Penny stocks with important dates to know this week. The post Best Penny Stocks To Buy?
4 Biotech Penny Stocks To Watch After EFTR Stock Jumps 351%
These penny stocks have upcoming events you should know about. The post 4 Biotech Penny Stocks To Watch After EFTR Stock Jumps 351% appeared first on Penny Stocks to Buy, Picks, News and Information | P...
Verastem Oncology to Present at Upcoming Investor Conferences
BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced that management will present vir...
These Reddit Penny Stocks Exploded Today, Are They On Your List?
These Reddit penny stocks popped off today, are they worth watching in 2021 The post These Reddit Penny Stocks Exploded Today, Are They On Your List? appeared first on Penny Stocks to Buy, Picks, News a...
Verastem Oncology Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress
BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today reported financial results for the three m...
Verastem Oncology Announces Updated Phase 1/2 FRAME Study Data in Low Grade Serous Ovarian Cancer Selected for a Mini...
BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced that an abstract detailing updat...
Verastem Oncology Announces Conversion of Senior Notes Eliminating Substantially All Outstanding Debt
BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced that it has converted all of the...
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq:VSTM), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced the grant of options to purchase ...
Verastem Oncology Appoints Paul Bunn, M.D., and Lesley Solomon to Board of Directors
BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq:VSTM), a biopharmaceutical company committed to developing and commercializing new medicines for patients battling cancer, today announced the appointm...
2 Biotech Penny Stocks That Are Vastly Superior Investments to Dogecoin
These unloved cancer stocks should dramatically outperform Dogecoin over the long haul.
Verastem (VSTM) Enters Overbought Territory
Verastem (VSTM) has moved higher as of late, but there could definitely be trouble on the horizon for this company.
These Penny Stocks Hit it Big Yesterday, Here's Why
Did these penny stocks slip by yesterday unnoticed? Here's 3 big gainers you may have missed The post These Penny Stocks Hit it Big Yesterday, Here's Why appeared first on Penny Stocks to Buy, Picks, Ne...
Verastem Oncology to Present at the 2021 Jefferies Virtual Healthcare Conference
BOSTON--(BUSINESS WIRE)--Verastem, Inc. (Nasdaq: VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced t...
Why Verastem Stock Is Crushing It Today
The biotech's experimental cancer treatment won an important regulatory designation today.
Verastem's VS-6766/Defactinib Combo Gets Breakthrough Therapy Tag For Ovarian Cancer; BTIG Upgrades Stock
The FDA has granted Breakthrough Therapy designation to Verastem Inc (NASDAQ: VSTM) for the combination of its investigational VS-6766, with defactinib, for recurrent low-grade serous ovarian cancer (LG...
Verastem Oncology Receives Breakthrough Therapy Designation for VS-6766 with Defactinib in Recurrent Low-Grade Serous...
BOSTON--(BUSINESS WIRE)--Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced th...